TARO - Taro Pharmaceutical Industries Ltd.

NYSE - NYSE Delayed Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
3/30/2019
3/30/2018
3/30/2017
3/30/2016
Cash flows from operating activities
Net Income
274,301
281,777
211,150
456,356
540,932
Depreciation & amortization
20,436
18,597
16,496
14,829
14,848
Deferred income taxes
14,269
12,262
56,007
73,706
-11,976
Stock based compensation
-
-
-
-
-
Change in working capital
7,665
37,182
7,660
-80,086
-137,163
Accounts receivable
-24,120
-32,088
-2,297
34,413
-16,386
Inventory
2,600
-5,515
-1,978
-3,770
-19,013
Accounts Payable
-
9,881
9,049
-2,290
-679
Other working capital
258,340
293,025
294,153
401,712
376,022
Other non-cash items
-
-
-227
273
-53
Net cash provided by operating activites
289,417
323,709
323,689
437,535
395,128
Cash flows from investing activities
Investments in property, plant and equipment
-31,077
-30,684
-29,536
-35,823
-19,106
Acquisitions, net
-
-
-
-
-
Purchases of investments
-1,123,144
-1,165,685
-1,140,853
-286,633
-300,824
Sales/Maturities of investments
1,157,317
1,453,505
927,676
196,170
-
Other investing activites
-
-
161,032
10
35,199
Net cash used for investing activites
3,096
257,136
-241,638
-117,778
-284,731
Cash flows from financing activities
Debt repayment
-
-
0
0
-5,888
Common stock issued
-
-
-
0
0
Common stock repurchased
-56,445
-88,849
-106,986
-294,897
-9,450
Dividends Paid
-
-500,000
-
-
-
Other financing activites
-
-
-
0
0
Net cash used privided by (used for) financing activities
-556,445
-588,849
-106,986
-294,897
-15,338
Net change in cash
-264,933
-9,160
-23,788
23,642
95,116
Cash at beginning of period
825,600
576,611
600,399
576,757
481,641
Cash at end of period
561,668
567,451
576,611
600,399
576,757
Free Cash Flow
Operating Cash Flow
289,417
323,709
323,689
437,535
395,128
Capital Expenditure
-31,077
-30,684
-29,536
-35,823
-19,106
Free Cash Flow
258,340
293,025
294,153
401,712
376,022